Two Sigma Securities, LLC Glaukos Corp Call Options Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
SELL
$76.4 - $96.33 $252,120 - $317,889
-3,300 Reduced 54.1%
2,800 $264,000
Q4 2023

Feb 14, 2024
BUY
$59.53 - $85.11 $142,872 - $204,264
2,400 Added 64.86%
6,100 $484,000
Q3 2023

Nov 14, 2023
SELL
$69.23 - $79.09 $138,460 - $158,180
-2,000 Reduced 35.09%
3,700 $278,000
Q2 2023

Aug 14, 2023
BUY
$45.44 - $71.21 $259,008 - $405,896
5,700 New
5,700 $405,000

Others Institutions Holding GKOS

# of Institutions
340
Shares Held
47.1M
Call Options Held
132K
Put Options Held
188K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.85B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email